Advertisement
UK markets closed

  • NIKKEI 225

    38,274.05
    -131.61 (-0.34%)
     

  • HANG SENG

    17,763.03
    +16.12 (+0.09%)
     

  • CRUDE OIL

    79.15
    -2.78 (-3.39%)
     

  • GOLD FUTURES

    2,328.80
    +25.90 (+1.12%)
     

  • DOW

    38,067.41
    +251.49 (+0.66%)
     

  • Bitcoin GBP

    45,943.77
    -2,072.08 (-4.32%)
     

  • CMC Crypto 200

    1,212.01
    -127.06 (-9.49%)
     

  • NASDAQ Composite

    15,734.61
    +76.79 (+0.49%)
     

  • UK FTSE All Share

    4,418.60
    -11.65 (-0.26%)
     
Money:

Family finances

Who is the breadwinner in your family and does it matter?

Novacyt shares jump after launch of new COVID-19 testing products

Sudip Kar-Gupta
Updated ·1-min read

By Sudip Kar-Gupta

PARIS (Reuters) - Healthcare and clinical diagnostics company Novacyt <ALNOV.PA> <NCYT.L>, whose shares have surged on the back of its COVID-19 testing products, on Thursday announced the launch of three new products to support testing for the presence of the virus.

The names of the new products are Exsig™ Direct, Exsig™ Mag and COVID-HT, Novacyt said.

The announcement of Novacyt's latest COVID-19 testing products pushed the company's Paris-listed shares up by around 10% by 0710 GMT, with the stock having jumped by around 1,600% since the start of 2020.

"As we continue to supply our COVID-19 test to laboratories around the world, we are delighted to provide further support through the launch of these new products," CEO Graham Mullis said.

ADVERTISEMENT

Novacyt has singled itself out with a test able to detect the new coronavirus in less than two hours. Standard testing, which also identifies other strains, takes up to a day.

(Reporting by Sudip Kar-Gupta; editing by Mark Potter and Jason Neely)